vs
Side-by-side financial comparison of LendingClub Corp (LC) and Varex Imaging Corp (VREX). Click either name above to swap in a different company.
LendingClub Corp is the larger business by last-quarter revenue ($252.3M vs $209.6M, roughly 1.2× Varex Imaging Corp). LendingClub Corp runs the higher net margin — 20.5% vs 1.1%, a 19.4% gap on every dollar of revenue. On growth, LendingClub Corp posted the faster year-over-year revenue change (15.9% vs 4.9%). Over the past eight quarters, LendingClub Corp's revenue compounded faster (16.1% CAGR vs 0.8%).
LendingClub Corporation is an American financial services company headquartered in San Francisco, California. It was the first peer-to-peer lender to register its offerings as securities with the Securities and Exchange Commission (SEC), and to offer loan trading on a secondary market. At its height, LendingClub was the world's largest peer-to-peer lending platform. The company reported that $15.98 billion in loans had been originated through its platform up to December 31, 2015.
Varex Imaging Corp is a global supplier of advanced imaging components and solutions, including X-ray tubes, digital flat panel detectors, and image processing software. Its products serve medical imaging, radiation oncology, and industrial non-destructive testing segments, with customers across key global markets.
LC vs VREX — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $252.3M | $209.6M |
| Net Profit | $51.6M | $2.3M |
| Gross Margin | — | 33.3% |
| Operating Margin | — | 7.3% |
| Net Margin | 20.5% | 1.1% |
| Revenue YoY | 15.9% | 4.9% |
| Net Profit YoY | 341.0% | 866.7% |
| EPS (diluted) | $0.44 | $0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $252.3M | $209.6M | ||
| Q4 25 | $266.5M | $228.9M | ||
| Q3 25 | $266.2M | $203.0M | ||
| Q2 25 | $248.4M | $212.9M | ||
| Q1 25 | $217.7M | $199.8M | ||
| Q4 24 | $217.2M | — | ||
| Q3 24 | $201.9M | $205.7M | ||
| Q2 24 | $187.2M | $209.1M |
| Q1 26 | $51.6M | $2.3M | ||
| Q4 25 | — | $12.2M | ||
| Q3 25 | $44.3M | $-89.1M | ||
| Q2 25 | $38.2M | $6.9M | ||
| Q1 25 | $11.7M | $-300.0K | ||
| Q4 24 | — | — | ||
| Q3 24 | $14.5M | $-51.1M | ||
| Q2 24 | $14.9M | $1.4M |
| Q1 26 | — | 33.3% | ||
| Q4 25 | — | 34.0% | ||
| Q3 25 | — | 33.3% | ||
| Q2 25 | — | 36.0% | ||
| Q1 25 | — | 34.3% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 32.6% | ||
| Q2 24 | — | 32.0% |
| Q1 26 | — | 7.3% | ||
| Q4 25 | 18.8% | 8.6% | ||
| Q3 25 | 21.5% | -39.8% | ||
| Q2 25 | 21.7% | 10.4% | ||
| Q1 25 | 7.2% | 5.6% | ||
| Q4 24 | 5.1% | — | ||
| Q3 24 | 8.9% | 5.3% | ||
| Q2 24 | 10.4% | 4.4% |
| Q1 26 | 20.5% | 1.1% | ||
| Q4 25 | — | 5.3% | ||
| Q3 25 | 16.6% | -43.9% | ||
| Q2 25 | 15.4% | 3.2% | ||
| Q1 25 | 5.4% | -0.2% | ||
| Q4 24 | — | — | ||
| Q3 24 | 7.2% | -24.8% | ||
| Q2 24 | 8.0% | 0.7% |
| Q1 26 | $0.44 | $0.05 | ||
| Q4 25 | $0.36 | $0.29 | ||
| Q3 25 | $0.37 | $-2.15 | ||
| Q2 25 | $0.33 | $0.17 | ||
| Q1 25 | $0.10 | $-0.01 | ||
| Q4 24 | $0.08 | — | ||
| Q3 24 | $0.13 | $-1.25 | ||
| Q2 24 | $0.13 | $0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $125.6M |
| Total DebtLower is stronger | — | $367.6M |
| Stockholders' EquityBook value | $1.5B | $476.9M |
| Total Assets | $11.9B | $1.1B |
| Debt / EquityLower = less leverage | — | 0.77× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $125.6M | ||
| Q4 25 | — | $155.1M | ||
| Q3 25 | — | $152.6M | ||
| Q2 25 | — | $223.0M | ||
| Q1 25 | — | $212.6M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $200.5M | ||
| Q2 24 | — | $190.0M |
| Q1 26 | — | $367.6M | ||
| Q4 25 | $0 | $367.5M | ||
| Q3 25 | $0 | $367.5M | ||
| Q2 25 | $0 | $567.2M | ||
| Q1 25 | $0 | $567.0M | ||
| Q4 24 | $0 | — | ||
| Q3 24 | — | $443.4M | ||
| Q2 24 | — | $443.1M |
| Q1 26 | $1.5B | $476.9M | ||
| Q4 25 | $1.5B | $472.6M | ||
| Q3 25 | $1.5B | $455.3M | ||
| Q2 25 | $1.4B | $549.7M | ||
| Q1 25 | $1.4B | $540.2M | ||
| Q4 24 | $1.3B | — | ||
| Q3 24 | $1.3B | $529.1M | ||
| Q2 24 | $1.3B | $581.2M |
| Q1 26 | $11.9B | $1.1B | ||
| Q4 25 | $11.6B | $1.1B | ||
| Q3 25 | $11.1B | $1.1B | ||
| Q2 25 | $10.8B | $1.4B | ||
| Q1 25 | $10.5B | $1.3B | ||
| Q4 24 | $10.6B | — | ||
| Q3 24 | $11.0B | $1.2B | ||
| Q2 24 | $9.6B | $1.3B |
| Q1 26 | — | 0.77× | ||
| Q4 25 | 0.00× | 0.78× | ||
| Q3 25 | 0.00× | 0.81× | ||
| Q2 25 | 0.00× | 1.03× | ||
| Q1 25 | 0.00× | 1.05× | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | — | 0.84× | ||
| Q2 24 | — | 0.76× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-16.1M |
| Free Cash FlowOCF − Capex | — | $-26.8M |
| FCF MarginFCF / Revenue | — | -12.8% |
| Capex IntensityCapex / Revenue | — | 5.1% |
| Cash ConversionOCF / Net Profit | — | -7.00× |
| TTM Free Cash FlowTrailing 4 quarters | — | $-13.3M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $-16.1M | ||
| Q4 25 | $-2.7B | $7.9M | ||
| Q3 25 | $-770.8M | $7.7M | ||
| Q2 25 | $-713.1M | $16.6M | ||
| Q1 25 | $-339.3M | $9.5M | ||
| Q4 24 | $-2.6B | — | ||
| Q3 24 | $-669.8M | $25.9M | ||
| Q2 24 | $-932.5M | $8.0M |
| Q1 26 | — | $-26.8M | ||
| Q4 25 | $-2.9B | $2.3M | ||
| Q3 25 | $-791.8M | $1.4M | ||
| Q2 25 | $-803.8M | $9.8M | ||
| Q1 25 | $-352.3M | $5.3M | ||
| Q4 24 | $-2.7B | — | ||
| Q3 24 | $-682.3M | $19.9M | ||
| Q2 24 | $-945.3M | $3.3M |
| Q1 26 | — | -12.8% | ||
| Q4 25 | -1076.0% | 1.0% | ||
| Q3 25 | -297.4% | 0.7% | ||
| Q2 25 | -323.5% | 4.6% | ||
| Q1 25 | -161.8% | 2.7% | ||
| Q4 24 | -1237.8% | — | ||
| Q3 24 | -338.0% | 9.7% | ||
| Q2 24 | -504.9% | 1.6% |
| Q1 26 | — | 5.1% | ||
| Q4 25 | 52.7% | 2.4% | ||
| Q3 25 | 7.9% | 3.1% | ||
| Q2 25 | 36.5% | 3.2% | ||
| Q1 25 | 6.0% | 2.1% | ||
| Q4 24 | 25.0% | — | ||
| Q3 24 | 6.2% | 2.9% | ||
| Q2 24 | 6.9% | 2.2% |
| Q1 26 | — | -7.00× | ||
| Q4 25 | — | 0.65× | ||
| Q3 25 | -17.41× | — | ||
| Q2 25 | -18.68× | 2.41× | ||
| Q1 25 | -29.07× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -46.33× | — | ||
| Q2 24 | -62.57× | 5.71× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LC
Segment breakdown not available.
VREX
| Medical Segment | $144.8M | 69% |
| Industrial Segment | $64.8M | 31% |
